WO2006057578A3 - Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent - Google Patents

Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent Download PDF

Info

Publication number
WO2006057578A3
WO2006057578A3 PCT/RU2005/000617 RU2005000617W WO2006057578A3 WO 2006057578 A3 WO2006057578 A3 WO 2006057578A3 RU 2005000617 W RU2005000617 W RU 2005000617W WO 2006057578 A3 WO2006057578 A3 WO 2006057578A3
Authority
WO
WIPO (PCT)
Prior art keywords
desynchronosis
correcting
chrono
preventing
biological
Prior art date
Application number
PCT/RU2005/000617
Other languages
French (fr)
Russian (ru)
Other versions
WO2006057578A2 (en
Inventor
Yuri Yurievich Gichev
Tatiana Germanov Gorokhovskaya
Evgeni Petrovich Volikov
Original Assignee
Yuri Yurievich Gichev
Tatiana Germanov Gorokhovskaya
Evgeni Petrovich Volikov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuri Yurievich Gichev, Tatiana Germanov Gorokhovskaya, Evgeni Petrovich Volikov filed Critical Yuri Yurievich Gichev
Publication of WO2006057578A2 publication Critical patent/WO2006057578A2/en
Publication of WO2006057578A3 publication Critical patent/WO2006057578A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to preventive medicine and can be used for preventing and correcting a functional desynchronosis of various organs and systems of a human organism, which are caused by professional and technogenic factors. Said invention makes it possible to develop a method for preventing and correcting a chronic desynchronosis taking into consideration the characters of the individual biorhythms of separate organs and systems of the human organism and chrono-biological correction agent for carrying out said method, which is based on a vegetable raw materials, vitamins, mineral substances and adaptogenes. The inventive method for preventing and correcting a chronic desynchronosis associated with the use of a biologically active correcting agent consists in pre-evaluating the organism physiological state, in determining, on the basis of the evaluation results, the degree of biorhythmic disorders and main desynchronosis evidences, in selecting peaks of the active and passive phases of individual biological rhythms and in assigning a peroral chrono-biological correction agent according to the organism physiological state, wherein the agent-taking time is selected according to the selected peaks of the active and passive phases of individual biological rhythms. A two-phase chrono-biological correction agent which is used for carrying out the inventive method and consists of morning and evening complexes is also disclosed.
PCT/RU2005/000617 2004-11-23 2005-11-23 Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent WO2006057578A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004135784/15A RU2317822C2 (en) 2004-11-23 2004-11-23 Means and method for carrying out chronobiological correction
RU2004135784 2004-11-23

Publications (2)

Publication Number Publication Date
WO2006057578A2 WO2006057578A2 (en) 2006-06-01
WO2006057578A3 true WO2006057578A3 (en) 2006-10-26

Family

ID=36498373

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2005/000617 WO2006057578A2 (en) 2004-11-23 2005-11-23 Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent

Country Status (2)

Country Link
RU (1) RU2317822C2 (en)
WO (1) WO2006057578A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493866C2 (en) * 2011-08-09 2013-09-27 Федеральное государственное бюджетное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Method for correction of sleep-wake schedule desynchronosis
RU2577701C1 (en) * 2015-03-17 2016-03-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) Agents having chronocorrective and adaptogenic activity
RU2601894C1 (en) * 2015-06-19 2016-11-10 Общество с ограниченной ответственностью "Хронокор" Chrono-biological correction agent
RU2645090C1 (en) * 2016-12-09 2018-02-15 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Method for prevention and treatment of polar desynchronosis
RU2674337C1 (en) * 2017-10-13 2018-12-07 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Remedy for seasonal desynchronosis correction
RU2688682C1 (en) * 2017-12-18 2019-05-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Петрозаводский государственный университет" Multimineral complex for prevention and correction of regional microelements in inhabitants of northern territories
RU2718050C2 (en) * 2018-09-18 2020-03-30 Наталья Вадимовна Карташова Medicinal collection with tonic and adaptogenic action

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2163795C1 (en) * 2000-03-02 2001-03-10 Сафоничева Ольга Георгиевна Method for making human organism functional state correction
RU2188047C2 (en) * 1997-06-11 2002-08-27 Институт физиологии СО РАМН Method for correcting human body desynchronosis due to air flight into another time zone
RU2234751C2 (en) * 1999-05-19 2004-08-20 Интернэшнл Бизнес Машинз Корпорейшн Method for combining and synchronizing data sets on recording medium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2188047C2 (en) * 1997-06-11 2002-08-27 Институт физиологии СО РАМН Method for correcting human body desynchronosis due to air flight into another time zone
RU2234751C2 (en) * 1999-05-19 2004-08-20 Интернэшнл Бизнес Машинз Корпорейшн Method for combining and synchronizing data sets on recording medium
RU2163795C1 (en) * 2000-03-02 2001-03-10 Сафоничева Ольга Георгиевна Method for making human organism functional state correction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IORDANSKAYA F.A.: "Osobennosti adaptatsii pri pereletakh na vostok i zapad, Sredstva korrektsii i profilaktiki desinkhrosa", ZH. TEORIYA I PRACTIKA FIZICHESKOI KULTURY, no. 3, 2000, pages 9 - 15, AND 1, AND 8 *

Also Published As

Publication number Publication date
RU2004135784A (en) 2006-05-10
RU2317822C2 (en) 2008-02-27
WO2006057578A2 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
WO2006057578A3 (en) Method for preventing and correcting a chronic desynchronosis of human organism organs and systems and a chrono-biological correction agent
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2004041269A3 (en) New use for pharmaceutical composition
EP2281561A3 (en) Use of LCK inhibitors for treatment of immunologic diseases
WO2006048450A3 (en) Peptides for use in the treating obesity
DE60127022D1 (en) Inverse latex based on squalane or hydrogenated polyisobutene and cosmetic compositions containing it, skin cosmetics, as well as pharmaceutical compositions
WO2006048452A3 (en) Peptides for use in treating of obesity
WO2006010517A3 (en) Diagnostics and therapeutics for diseases associated with fibroblast activation protein (fap)
WO2006002846A3 (en) New analogs of nitrobenzylthioinosine
MXPA02006511A (en) Complex comprising ocif and polysaccharide.
WO2005022146A3 (en) Diagnostics and therapeutics for diseases associated with kallikrein 13 (klk13)
WO2006021343A3 (en) Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3a (5-ht3a)
WO2004042402A3 (en) Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
ATE471520T1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH THE G-PROTEIN-COUPLED RECEPTOR ADIPOR1 (ADIPOR1).
WO2009035253A3 (en) Novel use of scoparone
WO2005090994A3 (en) Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1)
DE602004017439D1 (en) DIAGNOSTIC AND THERAPY PROCEDURES OF C5A RECEPTOR-ASSOCIATED DISEASES
ATE554393T1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH ADIPONECTIN RECEPTOR 2 (ADIPOR2).
WO2005113786A3 (en) Diagnostics and therapeutics for diseases associated with chymase (cma1)
WO2004097034A3 (en) Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
WO2006013013A3 (en) Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb)
WO2005085469A3 (en) Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1)
WO2006008003A3 (en) Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1)
WO2004080374A3 (en) Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c)
WO2005095631A3 (en) Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 alpha (mlk4 alpha)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 05851108

Country of ref document: EP

Kind code of ref document: A2